MOS
IOVA icon

MGO One Seven’s Iovance Biotherapeutics IOVA Stock Holding History

MGO One Seven’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.6K Buy
12,893
+235
+2% +$893 ﹤0.01% 1532
2026
Q1 		$44.4K Buy
12,658
+200
+2% +$640 ﹤0.01% 1393
2025
Q4 		$34K Buy
12,458
+1,420
+13% +$3.29K ﹤0.01% 1387
2025
Q3 		$24K Buy
+11,038
New +$26.1K ﹤0.01% 1322
2019
Q1 		– Sell
-38
Closed – – 1007
2018
Q4 		$0 Buy
+38
New +$366 ﹤0.01% 1853
2018
Q1 		$1K Hold
38
– – ﹤0.01% 1673
2017
Q4 		$0 Buy
+38
New +$305 ﹤0.01% 1786

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

MGO One Seven's IOVA Position: Q2 2026 in Review

MGO One Seven increased its Iovance Biotherapeutics (IOVA) stake by 1.9% in Q2 2026, buying an estimated $893 and bringing the position to 12,893 shares worth $53.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1532.

MGO One Seven first reported a position in IOVA in Q4 2017 and has held it in 7 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • MGO One Seven held 12,893 shares of Iovance Biotherapeutics worth $53.6K as of Q2 2026.
  • MGO One Seven bought 235 Iovance Biotherapeutics shares in Q2 2026, an estimated $893.
  • Iovance Biotherapeutics made up ﹤0.01% of MGO One Seven's portfolio in Q2 2026, its #1532 holding.
  • MGO One Seven first reported a position in Iovance Biotherapeutics in Q4 2017 and has held it in 7 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.